Molecules and Cells

Cited by CrossRef (8)

  1. Elisaveta Voynova, Damian Kovalovsky. From Hematopoietic Stem Cell Transplantation to Chimeric Antigen Receptor Therapy: Advances, Limitations and Future Perspectives. Cells 2021;10:2845
    https://doi.org/10.3390/cells10112845
  2. Tatiana Michel, Markus Ollert, Jacques Zimmer. A Hot Topic: Cancer Immunotherapy and Natural Killer Cells. IJMS 2022;23:797
    https://doi.org/10.3390/ijms23020797
  3. Nuno Jorge Lamas, Arnaud Martel, Sacha Nahon-Estève, Samantha Goffinet, Adam Macocco, Corine Bertolotto, Sandra Lassalle, Paul Hofman. Prognostic Biomarkers in Uveal Melanoma: The Status Quo, Recent Advances and Future Directions. Cancers 2021;14:96
    https://doi.org/10.3390/cancers14010096
  4. Xinxin Li, Shoubao Ma, Youcai Deng, Ping Yi, Jianhua Yu. Targeting the RNA m6A modification for cancer immunotherapy. Mol Cancer 2022;21
    https://doi.org/10.1186/s12943-022-01558-0
  5. Massimo Vitale, Monica Parodi. Blocking HIF to Enhance NK Cells: Hints for New Anti-Tumor Therapeutic Strategies?. Vaccines 2021;9:1144
    https://doi.org/10.3390/vaccines9101144
  6. Paresh Vishwasrao, Susanta K. Hui, D. Lynne Smith, Vishal Khairnar. Role of NK Cells in Cancer and Immunotherapy. Onco 2021;1:158
    https://doi.org/10.3390/onco1020013
  7. Mubin Tarannum, Rizwan Romee, Roman M. Shapiro. Innovative Strategies to Improve the Clinical Application of NK Cell-Based Immunotherapy. Front. Immunol. 2022;13
    https://doi.org/10.3389/fimmu.2022.859177
  8. Yang Zhou, Miao Li, Kuangyi Zhou, James Brown, Tasha Tsao, Xinjian Cen, Tiffany Husman, Aarushi Bajpai, Zachary Spencer Dunn, Lili Yang. Engineering Induced Pluripotent Stem Cells for Cancer Immunotherapy. Cancers 2022;14:2266
    https://doi.org/10.3390/cancers14092266